Search research articles
Contact Us
Filters
Showing results (471-480 of 587) with videos related to
Page
of 59
Sort By:
Cell Reports. Medicine
|
May 22, 2024
Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection
Ge-Xin Zhao, Xin-Yan Fang, Guo-Long Bu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival
Wen-Ting Liao, Li-Bing Song, Hui-Zhong Zhang, et al.
Nature Communications
|
November 17, 2021
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Frontiers in Oncology
|
September 25, 2020
Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma
Qi-Wen Li, Bo Qiu, Wan-Ming Hu, et al.
Plos One
|
November 8, 2007
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy
Jiang Li, Xue-hui Zeng, Hao-yuan Mo, et al.
Oncotarget
|
October 30, 2015
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma
Wen-Hui Chen, Lin-Quan Tang, Lu Zhang, et al.
Cell Death & Disease
|
September 2, 2016
RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma
Wen-Feng Hua, Qian Zhong, Tian-Liang Xia, et al.
Journal of Virology
|
March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>
Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Cancer Research
|
January 21, 2006
A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma
Ri-Cheng Jiang, Hai-De Qin, Mu-Sheng Zeng, et al.
Page
of 59
Search research articles
Search
Showing results (471-480 of 587) with videos related to
Sort By:
Page
of 59
Cell Reports. Medicine
|
May 22, 2024
Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection
Ge-Xin Zhao, Xin-Yan Fang, Guo-Long Bu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival
Wen-Ting Liao, Li-Bing Song, Hui-Zhong Zhang, et al.
Nature Communications
|
November 17, 2021
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Frontiers in Oncology
|
September 25, 2020
Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma
Qi-Wen Li, Bo Qiu, Wan-Ming Hu, et al.
Plos One
|
November 8, 2007
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy
Jiang Li, Xue-hui Zeng, Hao-yuan Mo, et al.
Oncotarget
|
October 30, 2015
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma
Wen-Hui Chen, Lin-Quan Tang, Lu Zhang, et al.
Cell Death & Disease
|
September 2, 2016
RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma
Wen-Feng Hua, Qian Zhong, Tian-Liang Xia, et al.
Journal of Virology
|
March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>
Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Cancer Research
|
January 21, 2006
A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma
Ri-Cheng Jiang, Hai-De Qin, Mu-Sheng Zeng, et al.
Page
of 59